U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976918) titled 'Registry Platform Myelofibrosis and Anemia' on April 29.
Brief Summary: The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease and to collect patient-reported outcomes for patients with primary and secondary myelofibrosis and anemia in Germany.
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Primary Myelofibrosis
Secondary Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis
Anemia
Myelofibrosis...